Insider · CIK 0001818524
Sanjay Chandru Keswani
officer
Files at NBIX (NEUROCRINE BIOSCIENCES INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock | +3,914 | $0.00 | $0 | 5,393 | 27 d ago |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -2,112 | $156.22 | $330k | 3,281 | 27 d ago |
| Jun 2, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Restricted Stock Unitderivative | +12,846 | $0.00 | $0 | 12,846 | Jun 4, 2025 |
| Jun 2, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Stock Optionderivative | +70,101 | $0.00 | $0 | 70,101 | Jun 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.